Gene · 4973
Papers4,129
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
861 to 880 of 4,129
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
Chlamydia pneumoniae is Prevalent in Symptomatic Coronary Atherosclerotic Plaque Samples Obtained From Directional Coronary Atherectomy, but its Quantity is Not Associated With Plaque Instability: An Immunohistochemical and Molecular Study. | Clin Pathol | 2022 | 36176379 | PubTator, text mining | PubMed |
| Mechanism of tonifying-kidney Chinese herbal medicine in the treatment of chronic heart failure. | Front Cardiovasc Med | 2022 | 36172573 | PubTator, text mining | PubMed |
| Myeloid-derived suppressor cells: an emerging target for anticancer immunotherapy. | Mol Cancer | 2022 | 36163047 | PubTator, text mining | PubMed |
| Oxidized low-density lipoprotein stimulates CD206 positive macrophages upregulating CD44 and CD133 expression in colorectal cancer with high-fat diet. | World J Gastroenterol | 2022 | 36160648 | PubTator, text mining | PubMed |
| From cerebral ischemia towards myocardial, renal, and hepatic ischemia: Exosomal miRNAs as a general concept of intercellular communication in ischemia-reperfusion injury. | Mol Ther Nucleic Acids | 2022 | 36159596 | PubTator, text mining | PubMed |
| Saffron and its active ingredients against human disorders: A literature review on existing clinical evidence. | Iran J Basic Med Sci | 2022 | 36159329 | PubTator, text mining | PubMed |
| Regulation of Atherosclerosis by Toll-Like Receptor 4 Induced by Serum Amyloid 1: A Systematic In Vitro Study. | Biomed Res Int | 2022 | 36158875 | PubTator, text mining | PubMed |
| The angiogenic genes predict prognosis and immune characteristics in esophageal squamous cell carcinoma: Evidence from multi-omics and experimental verification. | Front Oncol | 2022 | 36158681 | PubTator, text mining | PubMed |
| Damage-associated molecular patterns in vitiligo: igniter fuse from oxidative stress to melanocyte loss. | Redox Rep | 2022 | 36154894 | PubTator, text mining | PubMed |
| The serial changes of Neutrophile-Lymphocyte Ratio and correlation to weight loss after Laparoscopic Sleeve Gastrectomy. | Front Surg | 2022 | 36147694 | PubTator, text mining | PubMed |
| DPP4 as a Potential Candidate in Cardiovascular Disease. | J Inflamm Res | 2022 | 36147690 | PubTator, text mining | PubMed |
| Role of Immune Cells and Receptors in Cancer Treatment: An Immunotherapeutic Approach. | Vaccines (Basel) | 2022 | 36146572 | PubTator, text mining | PubMed |
| From Diabetes Care to Heart Failure Management: A Potential Therapeutic Approach Combining SGLT2 Inhibitors and Plant Extracts. | Nutrients | 2022 | 36145112 | PubTator, text mining | PubMed |
| The Improved Biocontrol Agent, F1-35, Protects Watermelon against Fusarium Wilt by Triggering Jasmonic Acid and Ethylene Pathways. | Microorganisms | 2022 | 36144312 | PubTator, text mining | PubMed |
| New Perspectives on Myeloid-Derived Suppressor Cells and Their Emerging Role in Haematology. | J Clin Med | 2022 | 36142973 | PubTator, text mining | PubMed |
| Estrogen Receptor Subtypes Elicit a Distinct Gene Expression Profile of Endothelial-Derived Factors Implicated in Atherosclerotic Plaque Vulnerability. | Int J Mol Sci | 2022 | 36142876 | PubTator, text mining | PubMed |
| A Novel L-Phenylalanine Dipeptide Inhibits the Growth and Metastasis of Prostate Cancer Cells via Targeting DUSP1 and TNFSF9. | Int J Mol Sci | 2022 | 36142828 | PubTator, text mining | PubMed |
| Modulation of Immune Cells as a Therapy for Cutaneous Lupus Erythematosus. | Int J Mol Sci | 2022 | 36142624 | PubTator, text mining | PubMed |
| The Effects of H2S and Recombinant Human Hsp70 on Inflammation Induced by SARS and Other Agents In Vitro and In Vivo. | Biomedicines | 2022 | 36140256 | PubTator, text mining | PubMed |
| The Impact of Tobacco Cigarettes, Vaping Products and Tobacco Heating Products on Oxidative Stress. | Antioxidants (Basel) | 2022 | 36139904 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/4973/papers?page=44